# Lixisenatide.

> PubMed lists PMID 28179743 in Hospital pharmacy as Journal Article, with publication-date metadata of 2017-01 (month precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28179743-lixisenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-05-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28179743-lixisenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28179743-lixisenatide-v1.json
- Content SHA-256: `770be1a99c10a9af8bfde5f3280a357d45e1eac43cf52507f22f58e877f999a1`

## Claims and source pins

### Headline

Lixisenatide. ([`pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93`](#source-pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93))

### Summary

PubMed lists PMID 28179743 in Hospital pharmacy as Journal Article, with publication-date metadata of 2017-01 (month precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93`](#source-pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93))

### Paragraph 1

PubMed lists PMID 28179743 in Hospital pharmacy as Journal Article, with publication-date metadata of 2017-01 (month precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93`](#source-pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93`](#source-pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93))

## Sources

<a id="source-pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93"></a>
- **Lixisenatide. · retained source version 1:2024-05-23:current:b33587b3ae9322ae9bf90902711e5e4334d25a57e90020679fa48e4b65c8609c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28179743/) (`pubmed-observation-pmid-28179743-2024-05-23-b33587b3ae93`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Lixisenatide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28179743-lixisenatide-v1.json SHA-256: 770be1a99c10a9af8bfde5f3280a357d45e1eac43cf52507f22f58e877f999a1.